News

A new study co-authored by Dr. Felice Schnoll-Sussman, Director of the Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian and Weill Cornell Medicine, shows promising results for combined colon and endometrial screening for patients with Lynch syndrome, a genetic condition in which individuals face up to a 60% lifetime risk of developing endometrial and gastrointestinal cancers.

This patient-centric program evolved from the desire to improve the quality of life and...

The Fund for the Future award supports selected junior faculty during a crucial period in their career development - the completion of their research training into the early years of their first faculty position at Weill Cornell Medicine. Backed by the generosity of donors to the Weill Department of Medicine (WDOM) and Iris Cantor Center for Women’s Health, funding is based upon academic progress and a competitive training award (such as an NIH K) application timeline within 18 months of...

Dr. David Artis, director of the Jill Roberts Institute and the Michael Kors Professor in Immunology, along with Dr. Chun-Jun Guo, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology and a scientist at the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine, and Dr. Frank Schroeder, a professor at the Boyce Thompson Institute and a professor in the Department of Chemistry and Chemical Biology in the...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.

In the study, published...